IMU Biosciences
IMU Biosciences is coupling deep, systems-level immune profiling with a proprietary AI platform to build a uniquely detailed immune atlas spanning the breadth of human health and disease
IMU Biosciences has raised €59M across 2 funding rounds from 2 investors, most recently a round in Jun 2026. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKwww.imubiosciences.com ↗
Total raised
€59M
€58,940,999
Funding rounds
2
Investors
2
distinct backers
Active since
2024-01
latest 2026-06
Funding by year
EUR raised per year · 2026 YTDIMU Biosciences — funding by year — interactive chart.
Data table
| IMU Biosciences — funding by year | |
|---|---|
| 2024 | €13M |
| 2026 | €45M |
Signals
High confidenceRaise-next likelihood24
base rate 30% for Other
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood18
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ Young (<3y)
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-06-02 | Other | €45M | IQ Capital,Molten Ventures | View deal → |
| 2024-01-24 | Series A | €13M | Molten Ventures | View deal → |